Geoffrey Thomas Gibney

8PUBLICATIONS
81CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingGene expression (incl. microarray and other genome-wide approaches)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 14, 2026
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial.

|May 22, 2026
Developing a Culturally Tailored Narrative Video for Skin Cancer Prevention Among Spanish-Speaking Hispanic Outdoor Workers: Co-Design Study.

|Mar 18, 2025
Large-Scale Multiomic Analysis Identifies Anatomic Differences and Immunogenic Potential in Subtypes of Leiomyosarcoma.

Galina Lagos, Roman Groisberg, Andrew Elliott

|Dec 20, 2023
Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study.

Pamela Munster, Nicholas Iannotti, Daniel C Cho

|Oct 18, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0.

Anna C Pavlick, Charlotte E Ariyan, Elizabeth I Buchbinder

|Nov 30, 2022
Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma.

Nikhil I Khushalani, Melinda Vassallo, Judith D Goldberg

Pageof 2

Frequent Collaborators

1 joint publications

Suthee Rapisuwon

1 joint publications

Michael B Atkins

1 joint publications

Anna C Pavlick

1 joint publications

Diwakar Davar